- Previous Close
68.26 - Open
68.00 - Bid 68.99 x --
- Ask 69.00 x --
- Day's Range
67.57 - 69.00 - 52 Week Range
47.62 - 89.89 - Volume
2,279,805 - Avg. Volume
4,066,717 - Market Cap (intraday)
87.281B - Beta (5Y Monthly) 2.26
- PE Ratio (TTM)
-- - EPS (TTM)
-0.23 - Earnings Date --
- Forward Dividend & Yield 0.32 (0.47%)
- Ex-Dividend Date Jun 3, 2024
- 1y Target Est
--
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides chemiluminescence series, assembly line series, nucleic acid series, dry type fluorescent immunoassay, and fully automatic blood type analyzer and reagents; ELISA kits; rapid diagnosis; bole series; and supporting reagents. The company was founded in 1991 and is headquartered in Beijing, China.
www.ystwt.comRecent News: 603392.SS
View MorePerformance Overview: 603392.SS
Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603392.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603392.SS
View MoreValuation Measures
Market Cap
86.36B
Enterprise Value
81.79B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
34.66
Price/Book (mrq)
6.95
Enterprise Value/Revenue
32.85
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-11.81%
Return on Assets (ttm)
-1.54%
Return on Equity (ttm)
-2.26%
Revenue (ttm)
2.49B
Net Income Avi to Common (ttm)
-294.04M
Diluted EPS (ttm)
-0.23
Balance Sheet and Cash Flow
Total Cash (mrq)
5.5B
Total Debt/Equity (mrq)
2.21%
Levered Free Cash Flow (ttm)
28.87M